Back

Comparison of 600 mg VS 300 mg clopidogrel loading dose for patients with ischemic heart disease: a meta-analysis of randomized controlled trials

1 September 2024 (17:00 - 17:50)
Organised by: Logo
Congress Presentation Part of: Bleeding and antiplatelet strategies in acute coronary syndromes Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Gwen Marcellana

Saint Lukes Medical Center Global City, Taguig (Philippines)

7 More presentations in this session

Presentation thumbnail
Temporal trends in major bleeding after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction from 2003 to 2017: the Western Denmark Heart Registry
Doctor P. Thrane (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Thirty days clinical outcomes following stent implantation with aspirin-free prasugrel monotherapy in non-ST segment elevation myocardial infarction. Interim report from ASET-Japan pilot study
Doctor K. Miyashita (Galway, IE)
Abstract Slides Video
Presentation thumbnail
Ticagrelor vs. clopidogrel in ST elevation myocardial infarction patients with hemoglobin > 160
Doctor T. Gu (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study
Doctor F. Bruno (Turin, IT) Doctor F. Wenzl (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Association of P2Y12 inhibitor pretreatment strategy with short and long term ischemic and bleeding outcomes in NSTE-ACS patients
Doctor K. Keskin (Hakkari, TR) Associate Professor A. Calik (Istanbul, TR)
Abstract Slides Video

Access the full session

Session thumbnail
Bleeding and antiplatelet strategies in acute coronary syndromes

The Event

Event poster

ESC Congress 2024

1 September 2024 17:00 CET
You may be interested in
thumbnail
Congress Presentation
Safety and efficacy of clopidogrel reloading in patients on chronic clopidogrel therapy presenting with ACS - a systematic review and meta-analysis
thumbnail
Congress Presentation
PANTHER - P2Y12 inhibitor or Aspirin moNoTHERapy as secondary prevention in patients with coronary artery disease
thumbnail
Congress Presentation
Effect of empagliflozin on no-reflow in patients with st elevation myocardial infarction undergoing primary percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources